Skip to content
10-Q

Quarterly Report

Immunocore Holdings plc IMCR

0001671927-26-000009

← back to feed
Filed
May 6, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 30, 2026 50.87M sh
Shares Diluted Q1 2026 · Mar 31, 2026 52.93M sh
Shares Diluted Q1 2026 · Mar 31, 2025 51.95M sh
Capex Q1 2026 · Mar 31, 2026 $1.78M
Capex Q1 2026 · Mar 31, 2025 $298K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$13.78M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $435K
Cash And Equivalents Q1 2026 · Mar 31, 2026 $452.68M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $467.71M
Stockholders Equity Q1 2026 · Mar 31, 2026 $393.67M
Stockholders Equity Q1 2026 · Dec 31, 2025 $381.03M
Stockholders Equity Q1 2026 · Mar 31, 2025 $378.48M
Stockholders Equity Q1 2026 · Dec 31, 2024 $360.72M
Current Liabilities Q1 2026 · Mar 31, 2026 $240.11M
Current Liabilities Q1 2026 · Dec 31, 2025 $246.7M
Total Liabilities Q1 2026 · Mar 31, 2026 $678.42M
Total Liabilities Q1 2026 · Dec 31, 2025 $686.24M
Current Assets Q1 2026 · Mar 31, 2026 $1B
Current Assets Q1 2026 · Dec 31, 2025 $996.74M
Total Assets Q1 2026 · Mar 31, 2026 $1.07B
Total Assets Q1 2026 · Dec 31, 2025 $1.07B
Eps Diluted Q1 2026 · Mar 31, 2026 $0.25
Eps Diluted Q1 2026 · Mar 31, 2025 $0.10
Eps Basic Q1 2026 · Mar 31, 2026 $0.26
Eps Basic Q1 2026 · Mar 31, 2025 $0.10
Sga Expense Q1 2026 · Mar 31, 2026 $37.85M
Sga Expense Q1 2026 · Mar 31, 2025 $40.2M
Rd Expense Q1 2026 · Mar 31, 2026 $61.11M
Rd Expense Q1 2026 · Mar 31, 2025 $56.47M
Net Income Q1 2026 · Mar 31, 2026 $12.97M
Net Income Q1 2026 · Mar 31, 2025 $5.02M
Operating Income Q1 2026 · Mar 31, 2026 $7.28M
Operating Income Q1 2026 · Mar 31, 2025 −$3.62M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $434K
Cost Of Revenue Q1 2026 · Mar 31, 2025 $831K
Revenue Q1 2026 · Mar 31, 2026 $106.68M
Revenue Q1 2026 · Mar 31, 2025 $93.88M